Veterinary Medicines

Acticarp 50 mg/ml, Solution for Injection

Not authorised
  • Carprofen
Download as PDF

Identifikacija zdravila

Ime zdravila:
Acticarp 50 mg/ml, Solution for Injection
Acticarp 50 mg/ml injekčný roztok pre hovädzí dobytok
Učinkovina:
Ciljne živalske vrste:
  • govedo
Pot uporabe:
  • Intravenska uporaba
  • Subkutana uporaba

Podatki o zdravilu

Učinkovina / Jakost:
  • Na voljo samo v English
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Farmacevtska oblika:
  • Raztopina za injiciranje
Withdrawal period by route of administration:
  • Intravenous use
    • govedo
      • Milk
        0
        hour
      • Meat and offal
        21
        day
  • Subcutaneous use
    • govedo
      • Milk
        0
        hour
      • Meat and offal
        21
        day
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QM01AE91
Pravni status za dobavo / izdajo zdravila:
  • Zdravilo, ki se izdaja na veterinarski recept
Status dovoljenja:
  • Surrendered
Authorised in:
Ta podatek za to zdravilo ni na voljo.
Opis ovojnine:

Dodatne informacije

Entitlement type:
Pravna podlaga za izdajo dovoljenja za promet z zdravilom:
Imetnik dovoljenja za promet z zdravilom:
  • Ecuphar
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
  • Laboratori Fundacio Dau
Pristojni organ:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Številka dovoljenja :
  • 96/022/DC/12-S
Datum spremembe statusa dovoljenja:
Referenčna država članica:
Številka postopka:
  • NL/V/0156/001

Dokumenti

Combined File of all Documents

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.
Slovak (PDF)
Objavljeno na: 28/01/2022
Prenesi
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."